Neonatal Genetics

New-born screening is a screening in infants shortly after birth for a list of conditions that are treatable, but not clinically evident in the new-born period. Some of the conditions included in new-born screening programs are only detectable after irreversible damage has been done, in some cases sudden death is the first manifestation of a disease. Screening programs are often run by state or national governing bodies with the goal of screening all infants born in the jurisdiction.

New-born screening originated with an amino acid disorderphenylketonuria (PKU), which can be easily treated by dietary modifications, but causes severe mental retardation if not identified and treated early.

  • Neonatal cellular bioenergetics
  • Neonatal pharmacokinetics
  • Neonatal screening
  • Fetal origins of adult disease
  • Maternal obesity

Related Conference of Neonatal Genetics

December 22-23, 2025

4th International Conference on Neonatology

Barcelona, Spain
January 26-27, 2026

27th World Congress on Pediatric Oncology and Cancer Care

Edinburgh, Scotland
February 23-24, 2026

6th Global Summit on Pediatric Nursing

Dubai, UAE
February 23-24, 2026

25th Annual World Congress on Neonatology

Dubai, UAE
February 26-27, 2026

10th World Pediatrics Conference

Amsterdam, Netherlands
March 17-18, 2026

5th World Congress on Pediatric Cardiology

Amsterdam, Netherlands
March 23-24, 2026

26th Annual Congress on Pediatrics & Neonatology

Rome, Italy
April 16-17, 2026

5th International Congress on Pediatrics

Tokyo, Japan
April 20-21, 2026

3rd World Congress on Pediatrics and Nutrition

Paris, France
April 23-24, 2026

11th Annual Pediatric Congress

Paris, France
May 21-22, 2026

39th World Pediatrics Conference

Paris, France
May 27-28, 2026

38th European Pediatrics Congress

Paris, France
June 04-05, 2026

30th World Nutrition and Pediatrics Healthcare Conference

Zurich, Switzerland

Neonatal Genetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in